• A Hybrid Conference and Internet Event
• Sponsored by Asia Pacific Healthcare Industry Compliance Team
• Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Pharmaceutical Compliance Forum (PCF)
• September 21 - 23, 2016
• Shangri-La Hotel, Singapore
• www.AsianPharmaCongress.com

SINGAPORE -- PHARMA UPDATE NEWS SERVICE™ -- JUNE 21, 2016: The Sixth Asia Pacific Pharmaceutical and Medical Device Compliance Congress, www.AsianPharmaCongress.com, will be held September 21 - 23, 2016, at the Shangri-La Hotel in Singapore. Registrants may attend the event in person or online (live webcast and archived for 6 months).

KEYNOTE SPEAKERS

Dante Beccaria Senior Vice President, Global Ethics & Business Integrity, Sanofi, Vice Chair, Code Committee Network, IFPMA, Paris, France Charles Cain, JD Deputy Chief, FCPA Unit, US Securities and Exchange Commission, Washington, DC Anne Nielsen, JD, LLM Senior Vice President, Chief Compliance and Ethics Officer, Bristol-Myers Squibb, New York, NY, USA Sophie Peresson, LLM, MA Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, London, UK Lori Queisser Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Former Sr. VP Global Compliance and Business Practices, Schering-Plough, Former Vice President, Chief Compliance Officer, Eli Lilly, Philadelphia, PA, USA Neill Stansbury, Esq. Co-founder and Director of the Global Infrastructure Anti-Corruption Centre, Chair, International Organization for Standardization Anti-Bribery Project Committee, Vice Chair, Anti-corruption Standing Committee, World Federation of Engineering Organization, Buckinghamshire, UK Eric Van Oppens Region President Asia & Russia at Alcon, a Novartis company, Former Head Asia Cluster, Novartis Pharma, Former Country President and CPO Head, Novartis South Korea, Singapore

FEATURED FACULTY

Dr. Milind Antani, MBBS, LLB Partner in charge-Pharma & Healthcare Practice, Nishith Desai Associates, Mumbai, India Alexander Bedenkov, MD, PhD Asia Area Medical Director, Astra Zeneca, Former Global Medical Director, Strategic Medical Affairs, Established Products (EPD), Abbott, Singapore Craig Brooks-Rooney Head, Asia-Pacific, Costello Medical Singapore, Singapore Eric Carlson, Esq. Partner, Covington & Burling LLP, Contributing Editor, FCPA Blog, Singapore Tom Chan, JD, LLM Head of Legal, Greater China, Takeda (China) Holdings Co. Ltd, Shanghai, China Chi Chen, MS Partner, Ernst & Young, Shanghai, China Eugene Chen, Esq. Partner, Beijing Office, Hogan Lovells International LLP, Shanghai, China Hwa-Soo Chung, Esq. Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea Campbell Clark, LLM Chief Ethics & Compliance Officer, Asia Pacific, Medtronic, Former General Counsel, Asia, Covidien, Singapore Michael Dusseau Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, New York, NY, USA Karen Eryou Senior Director, Corporate Compliance APAC, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Shanghai, China Giuseppe Falbo Regional Compliance Director (APAC and Russia), Alcon Laboratories, Inc., Singapore Andrew Frye, MBA Global Head, Business Unit Healthcare, Member of Group Management, DKSH, Bangkok, Thailand Mohit Grover Executive Director, Risk Consulting, Deloitte, Former Regional CIO, Astra Zeneca Asia Pacific, Singapore Andrew Ho Head of Ethics and Business Integrity, Australia and New Zealand, Sanofi, Former Compliance Associate, Novartis, Macquarie Park NSW, Australia David Hodgson Partner and Audit Advisory Global Lead, Deloitte, London, UK Katsumi Kojima Head of Ethics & Business Integrity-Japan, Sanofi Japan Group, Tokyo, Japan Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC, USA Dinesh Moudgil, MBA Partner, Ernst & Young, Mumbai, India Alison Parkes, PhD Vice President Compliance, IRAMEA (India, Russia, Asia, Middle East, Africa), Smith & Nephew, Singapore Yee Chung Seck, Esq. Partner and Lead, Pharmaceutical and Healthcare Practices, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam Sabina Sudan, LLB, LLM ECLS-Consults (Ethics / Compliance / Legal / Sustainability), Legal/International Compliance and Risk Management Professional, , Singapore and Delhi, India Belinda Tan Partner, Fraud Investigations & Dispute Resolutions, Ernst & Young, Singapore Emmanuel Vignal Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China Qi (Aaron) Yao, MA Compliance Manager, Cordis, Former Associate Manager, Training, Communication & Partnering, Compliance, Shanghai Roche Pharmaceuticals Ltd., Shanghai, China Riza Faith Ybanez, LLB Legal and Compliance Head - Oncology Asia Pacific, South Africa, Novartis Asia Pacific Pharmaceuticals Pte Ltd, Singapore Mike Zhao Head, Compliance China, UCB Pharma, Shanghai, China

TOPICS TO BE ADDRESSED

Anti-Corruption, including Working with Third Parties, Enforcement Activities, and Analytics for Fraud Detection Regional Regulators and Enforcement Updates A Report from Transparency International The Evolving Marketplace including Market Access, Procurement, Tendering, Innovation, Patient Support Programs, and Outcomes Research Updates on Local Codes and Transparency Initiatives Global/AP Regional Compliance Leader Perspectives: Key Risks They Consider and What They see Coming for the Future in Ethics and Compliance Programs Medical Affairs: Boundaries with Commercial Activities, MSLs, and Grants Managing Thoughtleader/KOL Relationships: Advisory Boards and Consulting Agreements, FMV, Conflicts of Interest, Multi-national Meetings Creating a Culture of Ethics and Compliance A Track for Newer Compliance Personnel Related to Basic Knowledge

The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.

The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.